» Articles » PMID: 28747190

Bone Mineral Density in People Living with HIV: a Narrative Review of the Literature

Overview
Journal AIDS Res Ther
Publisher Biomed Central
Date 2017 Jul 28
PMID 28747190
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Bone health status is largely absent in South Africa, the main reasons being the absence and cost-effectiveness of specific screening equipment for assessing bone mineral density (BMD). Various risk factors seem to play a role, some of which can be modified to change bone health status. Urbanisation is also a public health concern. Changing nutritional, as well as social behaviour, play integral roles in the prevalence and incidence of decreased BMD. Furthermore, human immunodeficiency virus (HIV) specifically, has a negative impact on BMD and although highly active antiretroviral therapy increases the prognosis for HIV-infected individuals, BMD still seem to decrease further. Dual energy X-ray absorptiometry is considered the gold standard for BMD assessment; however, recent developments have provided more cost-effective screening methods, among which heel quantitative ultrasound appears to be the most widely used in resource limited countries such as South Africa.

Citing Articles

Evaluation of bone mineral density and its influencing factors in patients infected with HIV under antiretroviral therapy.

Azarboo A, Hemmatabadi M, Fahimfar N, Faghihi Z, SeyedAlinaghi S, Shirzad N BMC Infect Dis. 2025; 25(1):33.

PMID: 39762767 PMC: 11706035. DOI: 10.1186/s12879-024-10388-y.


Bone Loss and Fractures in Post-Menopausal Women Living with HIV: A Narrative Review.

Jamshaid M, Heidari A, Hassan A, Mital D, Pearce O, Panourgia M Pathogens. 2024; 13(9).

PMID: 39339002 PMC: 11435029. DOI: 10.3390/pathogens13090811.


A Descriptive Analysis of Nasal Polyposis in HIV Positive Versus HIV Negative Patients.

Molokomme T, Maharaj S, Motakef S Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3289-3297.

PMID: 39130228 PMC: 11306855. DOI: 10.1007/s12070-024-04674-z.


Bone Disease in HIV: Need for Early Diagnosis and Prevention.

Schinas G, Schinas I, Ntampanlis G, Polyzou E, Gogos C, Akinosoglou K Life (Basel). 2024; 14(4).

PMID: 38672792 PMC: 11051575. DOI: 10.3390/life14040522.


IFNα induces CCR5 in CD4 T cells of HIV patients causing pathogenic elevation.

Le Buanec H, Schiavon V, Merandet M, How-Kit A, Song H, Bergerat D Commun Med (Lond). 2024; 4(1):52.

PMID: 38504093 PMC: 10951336. DOI: 10.1038/s43856-024-00453-7.


References
1.
Reginster J, Minne H, Sorensen O, Hooper M, Roux C, Brandi M . Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000; 11(1):83-91. DOI: 10.1007/s001980050010. View

2.
Bjarnason N, Christiansen C . Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone. 2000; 26(6):561-9. DOI: 10.1016/s8756-3282(00)00272-6. View

3.
Goodpaster B, Thaete F, Kelley D . Composition of skeletal muscle evaluated with computed tomography. Ann N Y Acad Sci. 2000; 904:18-24. DOI: 10.1111/j.1749-6632.2000.tb06416.x. View

4.
Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K . T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000; 408(6812):600-5. DOI: 10.1038/35046102. View

5.
Riggs B, Atkinson E, OFallon W, Eastell R, Khosla S . Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000; 106(12):1553-60. PMC: 381474. DOI: 10.1172/JCI10942. View